December 6, 2023
Alnylam Named One of America's Most Responsible Companies by Newsweek for 2nd Year in a Ro ...
Alnylam has been named one of America's Most Responsible Companies by Newsweek for the 2nd year in a row.
Read More ›
December 4, 2023
Being a Steward of the Planet in an Energy-Intensive Industry
Learn about how Alnylam is sourcing renewable energy for energy-intensive operations including manufacturing
Read More ›
November 30, 2023
Alnylam Named #1 Largest Employer in MA for 3rd Year in a Row by The Boston Globe
Alnylam has been named the #1 Largest Employer in MA for the 3rd year in a row and a Top Place to Work for the 9th year in a row.
Read More ›
October 26, 2023
Alnylam Named a Top Science Employer by Science Magazine for the 5th Year in a Row
Alnylam has been named a Science Magazine Top Employer for the 5th year in a row.
Read More ›
September 6, 2023
First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR Am ...
The Amyloidosis Alliance has published the first-ever consensus recommendations for patient- and family-centred holistic care in ATTRv.
Read More ›
July 24, 2023
Alnylam Named a Best Workplace for Millennials for 2023 by Fortune and Great Place to Work
Alnylam is ranked #19 on Fortune and Great Place to Work's 2023 list of Best Workplaces for Millennials.
Read More ›
July 11, 2023
Alnylam Named a Best Workplace for Innovators for the 3rd Year in a Row by Fast Company
Alnylam has been named a Fast Company Best Workplace for Innovators for 2023, our 3rd year in a row.
Read More ›
June 23, 2023
Alnylam in the Community: CASPAR Partnership Highlight
Alnylam has partnered with community organization CASPAR (Cambridge And Somerville Programs for Addiction Recovery) for many years.
Read More ›
May 3, 2023
Building a Corporate Responsibility Program from the Ground Up: Key Learnings from Alnylam ...
If you are building your program or assessing your program, here are five key learnings which may be helpful to your organization
Read More ›
April 24, 2023
2022 Annual Report: CEO Yvonne Greenstreet Reflects on the Next Chapter in the RNAi Revolu ...
Alnylam CEO Yvonne Greenstreet reflects on the company's accomplishments in 2022 and highlights of the 2022 annual report.
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site